High rate of systemic corticosteroid prescription among outpatient visits for psoriasis: A population‐based epidemiological study using the Korean National Health Insurance database. Issue 9 (22nd April 2017)

• Record Type: Journal Article
• Authors: Eun, Sang Jun; Jang, Sihyeok; Lee, Jin Yong; Do, Young Kyung; Jo, Seong Jin
• Is Part Of: Journal of dermatology. Volume 44:Issue 9(2017)
• Page Start: 1027
• Page End: 1032
• Publication Date: 2017-04-22
• Subjects: physicians -- prescriptions -- psoriasis -- steroids -- systemic corticosteroids; Dermatology -- Periodicals; Dermatology -- Japan -- Periodicals; Skin -- Diseases -- Periodicals; 616.5005
• DOI: 10.1111/1346-8138.13862
• Languages: English
• ISSNs: 0385-2407

Abstract

Abstract: The use of systemic corticosteroids (SC) for the treatment of psoriasis is not recommended according to textbooks and guidelines. In clinical practise, however, many physicians frequently prescribe SC for patients with psoriasis. To determine the magnitude of SC prescription for outpatients with psoriasis in Korea and identify factors associated with the use of SC, we used the 2010–2014 nationwide claims data of the Health Insurance Review and Assessment Service of Korea. In frequency analysis for the full scale of prescribed SC, oral methylprednisolone was the most frequently prescribed SC, followed by dexamethasone and betamethasone injections. The prescription rate of SC was 26.4% in outpatient visit episodes for psoriasis. The prescription rate of SC was higher in older patients, Medical Aid recipients, patients who visited office‐based physician practices and hospitals, and patients living in non‐metropolitan areas. In multiple logistic regression analyses, the older age group and smaller health‐care institutions were more associated with the SC prescription. In conclusion, SC were widely prescribed for patients with psoriasis in Korea despite the current guidelines. Both patients' individual and institutional characteristics were associated with the SC prescription.